Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran

Abstract

Background

Uropathogenic Escherichia coli O- Serogroups with their virulence factors are the most prevalent causes of UTIs. The present research performed to track common uropathogenic E.coli serogroups, antibiotic resistance pattern of strains and prevalence of virulence genes in isolations having the ability to constitute biofilm.

Methods

In this research 130 E.coli isolation from patients having UTI symptoms were collected and antimicrobial resistance pattern was performed by Kirby-Bauer method. Polymerase chain reaction was done using primer pairs to identify common serogroups of uropathogenic E.coli and studying virulence genes in isolations creating biofilm.

Results

Among 130 E.coli isolates, 80 (61.53 %) were able to make biofilm that 15 isolates (18.75 %) indicated strong reaction, 20 (25 %) of medium and 45 (56.25 %) of weak biofilm reaction. Among isolations creating biofilm, the highest resistance reported to Ampicillin (87.5 %) and the lowest to Nitrofurantoin (3.75 %). The frequency of fimH, pap, sfa and afa genes in isolations having the ability to create strong biofilm reported 93.33 %, 86.66 %, 86.66 % and 66.66 %, respectively.

Conclusions

The findings indicated the importance of virulence genes in serogroups producing uropathogenic E.coli biofilm. It is recommended that strains producing biofilm before antibiotic use should be studied.

Background

Urinary tract infections (UTI) are common causes of morbidity and sometimes lead to significant mortality. Escherichia coli (E. coli) was the most common etiological agent of UTI, accounting for nearly 80 % of community-acquired and 50 % of hospital-acquired infections [1] and tends to form microcolonies in mucosa lining of urinary bladder known as biofilm. These biofilms make the organism to resist the host immune response, more virulent and lead to the evolution of antibacterial drug resistance by enclosing them in an extracellular biochemical matrix [2]. Biofilms have a role in up to 60 % of human infections and they are very difficult to be eradicated with antimicrobial therapy. In vitro susceptibility tests have shown considerable increase in resistance of biofilm cells to killing [3]. Detection of biofilm-producer strains is therefore relevant for the design of adequate control measures for Uropathogenic E. coli (UPEC) infections.

The Escherichia coli strains are normally identified by serological typing of their H (flagellar), O (lipopolysaccharide) and in some cases, K (capsular) surface antigens. Overall, 184 O-serogroups are described for E. coli [4]. The O-serogroups of UPEC strains are related to certain virulence factor profile of each strain. Previous studies reported that O1, O2, O4, O6, O7, O8, O15, O16, O18, O21, O22, O25, O75 and O83 serogroups are preferentially associated with UPEC strains [5–13]. Some of the most important virulence genes of UPEC strains which are associated with severe UTIs are P fimbriae (pap), type 1 fimbriae, afimbrial adhesin I (afaI), hemolysin (hly), cytotoxic necrotizing factor 1 (cnf 1), aerobactin (aer), S fimbriae (sfa), adhesins and fimbriae [14, 15]; however, other virulence genes such as kpsMT, ompT, usp, iroN, iha, set 1, astA, group II capsule synthesis; sfa/foc, S and F1C fimbriae; iutA, traT, serum resistance; and fimH, are known to be involved in pathogenicity of this organism [16–18]. These Virulence factors help the organisms to colonize host surfaces, avoid and/or subvert host defense mechanisms, injure and/or invade host cells and tissues, and incite a noxious inflammatory response, thereby leading to clinical disease [19]. Uropathogenic E. coli strains more frequently produce Pap and Prs fimbrial adhesins. P fimbriae are important for colonization and persistence of E. coli in the colon and possibly facilitate spread to the urinary tract [20, 21]. The ability to constitute biofilm plays an important role in virulence of the bacteria, in addition to it; various genes encode urinary virulence factors.

In addition, several studies showed that antibiotic resistance in UPEC is increasing nowadays [22, 23]. Several studies have reported increasing trends in resistance against trimethoprim-sulfamethoxazole (TMP -SMZ) [24, 25] fluoroquinolones and other antibiotics, including ciprofloxacin [26, 27]. To reduce the rate of morbidity, an early treatment of UTIs is mandatory, which relays on empirical therapies. However, to initiate an effective empirical treatment, several factors must be taken into consideration, including geographical location, age and sex of the patient, and local antimicrobial resistance profiles of the pathogens.

The identification of bacterial resistance genes seems to be essential to reduce the treatment costs. Using phylogenetic grouping as defined by multilocus enzyme electrophoresis and muliplex polymerase chain reaction (PCR) assays, Johnson et al. reported detailed analyses about phylogenetic background and virulence attributes of uropathogenic E. coli strains isolated from urosepsis and cystitis [28]. To our knowledge, there is scarcity of data showing the common uropathogenic E. coli serogroups in causing urinary tract infections, antibiotic resistance pattern of strains and frequency distribution of types of virulence genes in isolations having the ability to constitute biofilm in Iran. Therefore, in this study, we determined to track the common uropathogenic E. coli serogroups, antimicrobial susceptibility patterns and the virulence gene distribution of UPEC strains having the ability to constitute biofilm isolated from patients with UTIs in Iran.

Methods

Bacterial strains and detection of uropathogenic E. coli serogroups and virulence genes

In the present study, a total of 130 E. coli strains isolates were isolated and collected from urine specimens of patients with UTI who that had been referred to the medical laboratory. The strains were isolated from pure cultures and identified and also confirmed biochemically and using molecular techniques in the laboratory.

The colonies were confirmed using Polymerase Chain Reaction (PCR) based on the detection of 16S rRNA gene region of E. coli described by Sabat et al., (2000) [29]. In addition, all isolates were serogrouped using PCR assays. Table 1 showed the primers used for detection of UPEC serogroups and the PCR conditions [30]. The oligonucleotide sequences and Multiplex Polymerase Chain Reaction conditions of the specific primers were used to amplify the pap, fimH, sfa and afa genes producing biofilm in uropathogenic E. coli are shown in Table 2 [30]. The amplified products were visualized by ethidium bromide staining after gel electrophoresis of 10 μL of the final reaction mixture in 1.5 % agarose.

Table 1.

The oligonucleotide primers and the Multiplex PCR programs used for amplification of O-serogroups genes of E. coli isolates

Serotypes	Gene	Primer name	Primer Sequence (5'-3)	Size of product (bp)	PCR programs	M-PCR Volume (50 μL)
O1	Wzx	wl-14632	GTGAGCAAAAGTGAAATAAGGAACG	1098	1 cycle: 95 °C ------------ 5 min. 30 cycle: 95 °C ------------ 30 s 62 °C ------------ 60 s 72 °C ------------ 60 s 1 cycle: 72 °C ------------ 5 min	5 μL PCR buffer 10X 2.5 mM Mgcl2 300 μM dNTP (Fermentas) 0.4 μM of each primers F & R 2 U Taq DNA polymerase (Fermentas) 3 μL DNA template
		wl-14633	CGCTGATACGAATACCATCCTAC
O6	Wzy	wl-14646	GGATGACGATGTGATTTTGGCTAAC	783
		wl-14647	TCTGGGTTTGCTGTGTATGAGGC
O7	Wzx	wl-14648	CTATCAAAATACCTCTGCTGGAATC	610
		wl-14649	TGGCTTCGAGATTAAACCTATTCCT
O8	orf469	wl-14652	CCAGAGGCATAATCAGAAATAACAG	448
		wl-14653	GCAGAGTTAGTCAACAAAAGGTCAG
O16	Wzx	wl-14654	GGTTTCAATCTCACAGCAACTCAG	302
		wl-14655	GTTAGAGGGATAATAGCCAAGCGG
O21	Wzx	wl-14676	CTGCTGATGTCGCTATTATTGCTG	209
		wl-14677	TGAAAAAAAGGGAAACAGAAGAGCC
O75	Wzy	wl-17413	GAGATATACATGGGGAGGTAGGCT	511
		wl-17414	ACCCGATAATCATATTCTTCCCAAC
O2	Wzy	wl-14636	AGTGAGTTACTTTTTAGCGATGGAC	770	1 cycle: 95 °C ------------ 5 min. 30 cycle: 94 °C ------------ 60 s 58 °C ------------ 60 s	5 μL PCR buffer 10X 2.5 mM Mgcl2 300 μM dNTP (Fermentas) 0.4 μM of each primers F & R 2 U Taq DNA polymerase (Fermentas)
		wl-14637	AGTTTAGTATGCCCCTGACTTTGAA
O4	Wzx	wl-14642	TTGTTGCGATAATGTGCATGTTCC	664
		wl-14643	AATAATTTGCTATACCCACACCCTC
O15	Wzy	wl-14672	TCTTGTTAGAGTCATTGGTGTATCG	183
		wl-14673	ATAAAACGAGCAAGCACCACACC
O18	Wzx	wl-14656	GTTCGGTGGTTGGATTACAGTTAG	551
		wl-14657	CTACTATCATCCTCACTGACCACG
O22	Wzx	wl-14660	TTCATTGTCGCCACTACTTTCCG	468
		wl-14661	GAAACAGCCCATGACATTACTACG
O25	Wzy	wl-14666	AGAGATCCGTCTTTTATTTGTTCGC	230
		wl-14667	GTTCTGGATACCTAACGCAATACCC
O83	Wzx	wl-14668	GTACACCAGGCAAACCTCGAAAG	362
		wl-14669	TTCTGTAAGCTAATGAATAGGCACC

Table 2.

The oligonucleotide primers and the Multiplex PCR programs used for amplification of virulence genes of E. coli isolates

Gene	Primer name	Primer sequence (5'-3)	Size of product (bp)	PCR program	M-PCR volume (50 μL)
pap	pap3 pap4	GCAACAGCAACGCTGGTTGCATCAT AGAGAGAGCCACTCTTATACGGACA	336	1 cycle: 94 °C ------------ 1 min. 30 cycle: 94 °C ------------ 60 s 63 °C ------------ 30 s 72 °C ------------ 90 s 1 cycle: 72 °C ------------ 5 min	5 μL PCR buffer 10X 1.25 mM Mgcl2 150 μM dNTP (Fermentas) 1 μM of each primers F & R 1.2 U Taq DNA polymerase (Fermentas) 3 μL DNA template
Sfa	sfa1 sfa2	CTCCGGAGAACTGGGTGCATCTTAC CGGAGGAGTAATTACAAACCTGGCA	410
Afa	afa1 afa2	GCTGGGCAGCAAACTGATAACTCTC CATCAAGCTGTTTGTTCGTCCGCCG	750
fimH	FimH1 FimH2	GAGAAGAGGTTTGATTTAACTTATTG AGAGCCGCTGTAGAACTGAGG	559	1 cycle: 94 °C ------------ 3 min. 40 cycle: 94 °C ------------ 60 s 58 °C ------------ 70 s 72 °C ------------ 70 s 1 cycle: 72 °C ------------ 6 min	5 μL PCR buffer 10X 2 mM Mgcl2 200 μM dNTP (Fermentas) 0.4 μM of each primers F & R 1 U Taq DNA polymerase (Fermentas) 3 μL DNA template

Detection of biofilm formation and antimicrobial susceptibility testing

All E. coli strains were included in the study and were analyzed for the production of biofilm and antimicrobial susceptibility pattern. Biofilm production in bacterial cultures was determined by Congo-red Agar method (CRA) as described previously by Solati et al. [31]. Congo-red was prepared as the aqueous solution, autoclaved, and then added when the agar cooled to 55 °C. Plates were inoculated and incubated for 24 hours at 37 °C. The positive isolate was indicated by black and dry crystalline colonies. Weak biofilm producers usually remained pink with the darkness at the center of colonies. Intermediate results were exhibited by the darkness of the colonies with the absence of a dry crystalline colonies.

Antimicrobial susceptibility testing was done by the Kirby–Bauer disc diffusion method using Mueller–Hinton agar (HiMedia Laboratories, Mumbai, India) according to the Clinical Laboratory Standards Institute (CLSI) guidelines [32] as has been previously described [30].

The antimicrobial agents tested and their corresponding concentrations were ampicillin (AM), tetracycline (TE), nalidixic acid (NA), co-trimoxazole (SXT), cephalothin (CF), ciprofloxacin (CP), norfloxacin (NOR), ceftriaxone (CRO), amikacin (AN), imipenem (IMP), gentamicin (GM) and nitrofurantoin (FM).

Statistical analysis

SPSS version 17.0 statistical software package was used for statistical analysis. Chi-square test was applied. P-value < 0.05 was considered statistically significant

Results

Among 130 E.coli isolates, 80 (61.53 %) were able to make biofilm. Among 80 E. coli strains subjected to biofilm production, 15 (18.75 %) strains showed highly positive with very black colonies color in Congo Red Agar (CRA), 20 strains (25 %) showed moderate positive with black colonies color in CRA, 45 strains (56.25 %) showed weakly positive with grey colonies color in CRA. Dry crystalline and black colonies at the Congo-red Agar culture, were considered as strong biofilm producers; isolates did not show dry crystalline black colonies were identified as moderately biofilm producers and non-biofilm producers showed pink or yellow colonies.

Antibiotic susceptibility pattern was studied for all E. coli isolates. The multi-drug resistant pattern of the biofilm producing and non producing UPEC E. coli is shown in Table 3. All the biofilm forming strains showed maximum resistance to ampicillin (87.5 %), followed by tetracycline (75 %), nalidixic Acid (72.5 %) and co-trimoxazole (71.25 %). Both biofilm producer and non- biofilm producer were highly resistant to ampicillin, followed by tetracycline and nalidixic acid. 93.75 % and 98 % sensitive was noticed for biofilm and non-biofilm producer against nitrofurantoin, respectively.

Table 3.

Antibiotic resistance pattern of the biofilm producing and non producing Uropathogenic E. coli

Antibiotic	Biofilm producer (N = 80)		Non biofilm producer (N = 50)
	Resistance	Sensitive	Resistance	Sensitive
Ampicillin (AM)	70 (87.5 %)	10 (12.5 %)	40 (80 %)	10 (20 %)
Tetracycline (TE)	60 (75 %)	20 (25 %)	35 (70 %)	15 (30 %)
Nalidixic Acid (NA)	58 (72.5 %)	22 (27.5 %)	34 (68 %)	16 (32 %)
Co-Trimoxazole (SXT)	57 (71.25 %)	23 (28.75 %)	33 (66 %)	17 (34 %)
Cephalothin (CF)	45 (56.25 %)	35 (43.75 %)	28 (56 %)	22 (44 %)
Ciprofloxacin (CP)	45 (56.25 %)	35 (43.75 %)	27 (54 %)	23 (46 %)
Norfloxacin (NOR)	43 (53.75 %)	37 (46.25 %)	26 (52 %)	24 (48 %)
Ceftriaxone (CRO)	33 (41.25 %)	47 (58.75 %)	20 (40 %)	30 (60 %)
Amikacin (AN)	31 (38.75 %)	49 (61.25 %)	18 (36 %)	32 (64 %)
Imipenem (IMP)	25 (31.25 %)	55 (68.75 %)	15 (30 %)	35 (70 %)
Gentamicin (GM)	15 (18.75 %)	65 (81.25 %)	9 (18 %)	41 (82 %)
Nitrofurantoin (FM)	5 (6.25 %)	75 (93.75 %)	1 (2 %)	49 (98 %)

Our results revealed high distribution of UPEC serogroups isolated from patients with urinary tract infection. Totally, O25 (26.66 %), O15 (20.0 %) and O16 (13.33 %) had the highest biofilm producing serogroups while O2, O4, O6, O8, O21 and O22 had the lowest biofilm producing serogroups which showed (6.66 %) among Uropathogenic E. coli isolates detected (Table 4).

Table 4.

Prevalence of serogroups Uropathogenic E. coli

Number of positive samples	Prevalence of serogroups (%)
	O1	O2	O4	O6	O7	O8	O15	O16	O18	O21	O22	O25	O75	O83
High Biofilm Production E. coli (N = 15)	-	1 (6.66 %)	1 (6.66 %)	1 (6.66 %)	-	1 (6.66 %)	3 (20 %)	2 (13.33 %)	-	1 (6.66 %)	1 (6.66 %)	4 (26.66 %)	-	-
Moderate Biofilm Production E. coli (N = 20)	1 (5 %)	1 (5 %)	1 (5 %)	1 (5 %)	1 (5 %)	1 (5 %)	3 (15 %)	2 (10 %)	1 (5 %)	1 (5 %)	1 (5 %)	5 (25 %)	1	-
Weak Biofilm Production E. coli (N = 45)	1 (2.22 %)	1 (2.22 %)	2 (4.44 %)	6 (13.33 %)	1 (2.22 %)	1 (2.22 %)	10 (22.22 %)	5 (11.11 %)	1 (2.22 %)	2 (4.44 %)	1 (2.2 %)	13 (28.88 %)	1 (2.22 %)	-
No biofilm E. coli (N = 50)	1 (2 %)	1 (2 %)	3 (6 %)	8 (16 %)	2 (4 %)	1 (2 %)	11 (22 %)	1 (2 %)	1 (2 %)	4 (8 %)	1 (2 %)	14 (28 %)	1 (2 %)	1 (2 %)

In the present study the prevalence of fimH, pap, sfa and afa genes in Uropathogenic E. coli was determined and the result showed that among high biofilm producer Uropathogenic E. coli isolates fimH gene was the highest prevalence and afa gene was the lowest prevalence virulence gene (Table 5). Biofilm production was significantly associated with fimH, pap, afa and sfa virulence genes (P < 0.05).

Table 5.

Prevalence of fimH, pap, sfa and afa genes in Uropathogenic E. coli

Virulence gene	UPEC E. coli
	High biofilm producer 15	Moderate biofilm producer 20	Weak biofilm producer 45	Non biofilm producer 50	P value
fimH	14 (93.33 %)	18 (90 %)	35 (77.77 %)	30 (60 %)	0.031
pap	13 (86.66 %)	16 (80 %)	30 (71.42 %)	28 (56 %)	0.001
sfa	13 (86.66 %)	10 (50 %)	20 (44.44 %)	20 (40 %)	0.033
afa	10 (66.66 %)	7 (35 %)	15 (33.33 %)	10 (20 %)	0.035

Discussion

Urinary tract infections are among the most common bacterial diseases worldwide which involve (infects) about 250 million people in developing countries annually [33, 34]. Uropathogenic E. coli alone account for 70-90 % of the UTI infections [35, 36] and their susceptibility patterns against different antibiotics vary in different geographical regions, eventually leading to empirical therapy which is based on the local susceptibility profiles. Bacterial biofilm are often associated with long-term persistence of organism in various environments. Bacteria in biofilm display dramatically increased resistance to antibiotics [37].

Among 80 E. coli isolates subjected to biofilm production, 15 (18.75 %) isolates showed highly positive, 20 isolates (25 %) showed moderate positive, 45 isolates (56.25 %) showed weakly positive in Congo Red Agar method (CRA). Antibiotic susceptibility pattern was studied for all E. coli isolates.

The biofilm forming isolates showed maximum resistance to Ampicillin (87.5 %), followed by Tetracycline (75 %), Nalidixic Acid (72.5 %) and Co-Trimoxazole (71.25 %). Both biofilm producer and non- biofilm producer were highly resistant to Ampicillin, followed by Tetracycline and Nalidixic Acid. 93.75 % and 98 % sensitivity was noticed for biofilm and non-biofilm producer against Nitrofurantoin, respectively. The findings of the current investigations are in agreement with the reports of Reisner et al. [38] ; Ong et al. [39]; Ulett et al. [40] and Ulett et al. [41] in which a greater variation was observed against the uropathogenic E. coli forming biofilms under different conditions. Another finding of this study is that strong biofilm producers were less susceptible to antimicrobial agents than the non-biofilm producer. This result may agree with the previous studies showing that the sessile bacterial cells seems to exhibit higher resistance than the planktonic cells [42–48], so the findings of the current investigation indicated that resistance mechanisms are associated with the formation of biofilm among uropathogenic E. coli.

Similarly, the increasing prevalence of multi-drug resistance (MDR) has been reported by other workers showed, of the 100 (60.2 %) E. coli strains, 72 strains displayed a biofilm positive phenotype under the optimized conditions in the Congo Red agar medium and the strains were classified as highly positive (17, 23.6 %), moderate positive (19, 26.3 %) and weakly positive (36, 50.0 %). The rates of antibiotic resistance of biofilm producing E. coli were found to be 100 % for chloramphenicol and amoxyclav (amoxicillin and clavulanic acid), 86 % for gentamicin and cefotaxime, 84 % for ceftazidime, 83 % for cotrimoxazole and piperacillin/tazobactam, 75 % for tetracycline and 70 % for amikacin [49]. This could be due to dissemination of MDR strains in hospital settings and the different combination of antibiotics resulted in varying degree of resistance among the biofilm producing uropathogenic E. coli.

In addition, 56.25 % of biofilm-producing UPEC isolates showed resistance to Cephalothin. Similar findings had been previously observed in South East Asian region [50–52]. Reported resistance rate against these drugs was comparatively lower in previous study in Iran (19.6 %) [53] and in Bangladesh, it was 32 % [54]. However, observed higher percentages of resistances against Cephalothin drugs indicated that they could render their efficacies as therapeutic agents, particularly in Iranian population. In general, our results suggest that transformation of UTI-associated E. coli with plasmids carrying different antibiotic resistance gene had a significant impact on biofilm formation and that these effects were both strain dependent and varied between different antibiotics.

Our results revealed high distribution of UPEC serogroups isolated from patients with urinary tract infection. Totally, O25 (26.66 %), O15 (20.0 %) and O16 (13.33 %) had the highest biofilm producing serogroups while O2, O4, O6, O8, O21 and O22 had the lowest biofilm producing serogroups which showed (6.66 %) among Uropathogenic E. coli isolates detected (Table 4). In the present study the prevalence of fimH, pap, sfa and afa genes in Uropathogenic E. coli was determined and the result showed that among High biofilm producer Uropathogenic E. coli isolates fimH gene was the highest prevalence and afa gene was the lowest prevalence virulence gene (Table 5). Biofilm production was significantly associated with fimH, pap, afa and sfa virulence genes (P < 0.05). Manuela et al. reported that Biofilm production was significantly associated with fluoroquinolone resistance at all incubation time points and was independent of the media used (P < 0.05). Biofilm production was not associated with cnf1, hly, pap and sfa genes (P > 0.05), but was significantly associated with afa, aer and the β-lactamase genes (P < 0.05) [55].

Conclusions

Urinary tract infections are one of the common infections which are encountered in the clinical practice. This study reveals the prevalence and antimicrobial susceptibility pattern of biofilm and non-biofilm producing uropathogenic E. coli strains. Biofilm formation is closely related with the resistance of E. coli towards the antimicrobial drugs and also it increases the chronicity of urinary tract infection. In general, the current study demonstrated a high tendency among the clinical isolates of E. coli to form biofilm. The present study has also shown the production of various virulent factors and developing drug resistance in UPEC. Antibiotic resistance may provide a substantial advantage to the survival of the pathogen. The drug resistance among UPEC is on rise therefore the selection of appropriate antibiotics (after antibiotic susceptibility testing) is must for proper treatment of patients and to avoid emergence of drug resistance. Therefore, the knowledge of virulence factors of E. coli and their antibiotic susceptibility pattern will help in better understanding of the organism and in the treatment of UTI.

Abbreviations

UPEC

Uropathogenic E. coli

UTIs

Urinary Tract Infections

E. coli

Escherichia coli

aer

Aerobactin

pap

P fimbriae

afa I

Type 1 fimbriae, afimbrial adhesin

hly

Hemolysin

cnf 1

Cytotoxic necrotizing factor 1

sfa

S fimbriae

PCR

Polymerase chain reaction

CRA

Congo red agar

CLSI

Clinical and Laboratory Standards Institute

MHA

Mueller Hinton agar

AM

Ampicillin

TE

Tetracycline

NA

Nalidixic acid

SXT

Co-trimoxazole

CF

Cephalothin

CP

Ciprofloxacin

NOR

Norfloxacin

CRO

Ceftriaxone

AN

Amikacin

IMP

Imipenem

GM

Gentamicin

FM

Nitrofurantoin

SPSS

Statistical package for the social sciences